Citi raised the firm’s price target on Zai Lab (ZLAB) to $69 from $66 and keeps a Buy rating on the shares. The firm updated the company’s model post the Q2 report.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLAB:
- Zai Lab Reports Growth and Strategic Progress in Q2 2025
- Zai Lab reports Q2 EPS (4c), consensus (42c)
- Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
- Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
- Zai Lab price target raised to $75 from $73 at Leerink